NASDAQ:ALBT • US05344R3021
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVALON GLOBOCARE CORP (ALBT).
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.2M -13.67% | 1.256M 4.64% | 1.333M 6.19% | |
| EBITDA YoY % growth | -7.11M 0.42% | -6.97M 1.96% | -3.792M 45.59% | |
| EBIT YoY % growth | -7.44M 0.13% | -7.182M 3.47% | -3.97M 44.72% | |
| Operating Margin | -620.00% | -571.95% | -297.74% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
AVALON GLOBOCARE CORP (ALBT) will report earnings on 2026-03-30.